In a study, 43 patients with advanced melanoma allocated to intradermal (n = 21) and intranodal (n = 22) groups were treated with a DC vaccine pulsed with melanoma antigens gp100 and tyrosinase peptides together with KLH. This evidence concerns the gene PMEL and melanoma.